The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Workshop of the Carolinas 2024 | Advancements in combination strategies with JAK inhibitors for myelofibrosis
In this video, Alexander Coltoff, MD, Medical University of South Carolina, Charleston, SC, briefly outlines advancements in combination strategies with JAK inhibitors for patients with myelofibrosis (MF). This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Advisory Board: Blueprint Medicines, CTI Biopharma.
